Advertisement

Topics

assume risk-adj. peak sales of $1.5bn in 2029 with $604mn in DS, $503mn in LGS, $386mn in other pediatric epilepsies. Based on positive feedback from physicians and high unmet need, we assume 60% peak penetration in DS, 20% in LGS and 7.5% in other pediat

20:08 EDT 14 Sep 2018 | tgtxdough

assume risk-adj. peak sales of $1.5bn in 2029 with $604mn in DS, $503mn in LGS, $386mn in other pediatric epilepsies. Based on positive feedback from physicians and high unmet need, we assume 60% peak penetration in DS, 20% in LGS and 7.5% in other pediatric epilepsie

Original Article: assume risk-adj. peak sales of $1.5bn in 2029 with $604mn in DS, $503mn in LGS, $386mn in other pediatric epilepsies. Based on positive feedback from physicians and high unmet need, we assume 60% peak penetration in DS, 20% in LGS and 7.5% in other pediat

NEXT ARTICLE

More From BioPortfolio on "assume risk-adj. peak sales of $1.5bn in 2029 with $604mn in DS, $503mn in LGS, $386mn in other pediatric epilepsies. Based on positive feedback from physicians and high unmet need, we assume 60% peak penetration in DS, 20% in LGS and 7.5% in other pediat"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...